Precision for Medicine Acquires ACT Oncology         

ACT Oncology Appoints New Chief Medical Officer

ACT Oncology (ACT), an oncology specialist Clinical Research Organization (CRO), is pleased to announce the appointment of Gerald Messerschmidt, M.D., FACP, as Chief Medical Officer (CMO).  Formerly a consultant for the company, Dr. Messerschmidt will provide medical and safety leadership in addition to lending his expertise to the development of Sponsors’ clinical development strategies.  Dr. Messerschmidt is American Board of Medical Specialty Certified in Internal Medicine, Medical Oncology and Hematology and has over 25 years of experience in oncology drug development.

Read Full Article

We're changing our name and website to reflect our exciting new capabilities since joining Precision for Medicine. Please visit us at precisionforoncology.com to see how we’re delivering the next generation of CRO services for oncology innovators.